| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2005;130:837-843
© 2005 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
a Department of Pediatrics, Glenrose Rehabilitation Hospital; Edmonton, Alberta, Canada.
b Department of Surgery, University of Alberta, Glenrose Rehabilitation Hospital; Edmonton, Alberta, Canada.
c Child Health Outcomes Unit, Glenrose Rehabilitation Hospital; Edmonton, Alberta, Canada.
Received for publication February 1, 2005; revisions received April 15, 2005; accepted for publication April 25, 2005. * Address for reprints: Dr P-Y Cheung, Department of Newborn Medicine, Royal Alexandra Hospital, 10240 Kingsway Ave, Edmonton, Alberta, Canada T5H 3V9. (Email: poyin{at}ualberta.ca).
 |
Abstract |
|---|
 Top Abstract IntroductionPatients and MethodsResultsDiscussionConclusionReferences |
|---|
METHODS: A total of 85 infants with congenital heart disease underwent intracardiac surgery between 1996 and 1999. Differences in serial lactate concentrations after surgery among 3 outcome groups were compared. The predictive value of plasma lactate concentration on outcome (1) at discharge from initial hospitalization and (2) 18 to 24 months postnatal age was examined.
RESULTS: Compared with survivors, the nonsurvivors had higher lactate concentrations on admission to the pediatric intensive care unit at day 1 peak and area under the curve of the lactate profile than those of adverse and intact survivors (all P < .001, analysis of variance). Significant differences in the time for lactate concentrations to return to 2 mmol/L or less during the first postoperative day were observed among the groups: nonsurvivors > adverse survivors > intact survivors. Lactate concentrations of less than 7 mmol/L on admission or less than 8 mmol/L at day 1 peak predicted survival with 82% sensitivity and 83% specificity, and positive and negative predictive values of 97% and 43%, respectively (P < .001, 
2). Plasma lactate concentrations were associated with adverse outcome but had lower predictive values compared with that for nonsurvival.
CONCLUSIONS: Serial lactate determination accurately predicts survival and may help differentiate survivors with adverse outcome from those with intact neurodevelopment in early childhood.
|
Introduction |
|---|
|
TopAbstractIntroductionPatients and MethodsResultsDiscussionConclusionReferences |
|---|
Increasing attention is now being given to the outcome of infants surviving after intracardiac surgery.
2
Acute mortality during initial hospitalization usually relates to the perioperative severity of the illness and is associated with multiorgan failure.
3
However, the determinants of developmental outcome of infants surviving intracardiac surgery are multifactorial, including brain injury before, during, and after surgery, as well as environmental factors such as the socioeconomic status of the family.
4
Intraoperative risk factors, such as the deep hypothermic circulatory arrest time
5,6
and neuroimaging
7
and electrophysiologic
5,8
findings, have been shown to correlate with mortality rates and neurodevelopmental morbidity after intracardiac surgery in infants. Recently, in a prospective study of young infants (<2 years of age) with complex congenital heart disease excluding hypoplastic left heart syndrome (HLHS) and other congenital anomalies, Limperopoulos and associates
9
identified the following clinical characteristics that increase the risk for persistent developmental deficits: preoperative and acute postoperative neurodevelopmental status, microcephaly, type of heart lesion, length of deep hypothermic circulatory arrest, age at operation, and days in the intensive care unit. Some of these factors, however, are observer-dependent or occur late in the course of initial hospitalization.
Plasma lactate is a conventional indicator of tissue hypoxia
10
and has been widely used in the management of critically ill patients. Hyperlactatemia correlates with mortality in adults, children, and neonates.
11-14
After intracardiac surgery in young infants, the predictive value (PV) of lactate concentration on postoperative mortality is supported by some studies,
15-18
whereas Hatherill,
19
Munoz,
20
and their associates, both reported low positive PV (32%-45%) for mortality despite an optimal sensitivity and specificity of approximately 80%. Although the discrepancy may be related to developmental changes in lactate metabolism, a detailed examination of plasma lactate profile during the postoperative period and its relationship with the neurodevelopmental outcome in this population may help establish its value in patient management.
To date, limited information is available on the relationship between postoperative plasma lactate profile and the outcome of neonates undergoing intracardiac surgery and followed prospectively with comprehensive and standardized neurodevelopmental assessment. In our previous report on outcome predictors in a cohort of 85 infants, preliminary findings suggested plasma lactate as an independent predictor.
21
Therefore, we investigated the PV of serial lactate determination on the mortality and neurodevelopment in early childhood of neonates with complex congenital heart disease who underwent intracardiac surgery within 6 weeks of age. We hypothesized that infants with persistently elevated plasma lactate concentrations had a higher likelihood of dying during the acute hospitalization period and had abnormal neurodevelopmental outcome in early childhood if they survived.
|
Patients and Methods |
|---|
|
TopAbstractIntroductionPatients and MethodsResultsDiscussionConclusionReferences |
|---|
From September 1996 to August 1999, after informed consent, all infants with complex congenital heart disease who were admitted to the Stollery Children's Hospital and who underwent intracardiac surgery at the age of 6 weeks or less were prospectively included in a multicenter cohort study to examine predictors associated with outcome.
21
During the 3-year study period, 85 consecutively admitted, eligible infants (68% were male, 81% were white) were enrolled in the study. Primary cardiac diagnoses included transposition of great arteries with or without ventricular septal defect (23, 27%), HLHS (26, 31%), total anomalous pulmonary venous drainage (6, 7%), truncus arteriosus (9, 10%), complex anomalies involving the aortic arch or mitral valve (16, 19%), and other complex cardiac lesion (5, 6%).
As part of the postoperative management of these sick infants, plasma lactate concentrations were measured on or soon after admission to the intensive care unit and frequently during the first 72 postoperative hours to assess tissue oxygenation. Any decision to withdraw or discontinue treatment was not based solely on plasma lactate concentration. Because this was a retrospective analysis of convenient sampling of lactate levels, patients who had normal lactate levels or died soon after admission had few lactate determinations. The blood samples were preserved on ice, if not run immediately, and sent for plasma lactate concentration assay immediately by enzymatic spectrometric methods (normal range: 0.5-2.0 mmol/L). For this study, serial plasma lactate concentrations of individual patients obtained during the entire postoperative period were plotted on individual time-scaled charts for subsequent calculations as appropriate.
Multidisciplinary assessments were performed at 18 to 24 months of age at the Neonatal and Infant Follow-up Clinic at the Glenrose Rehabilitation Hospital, Edmonton, Alberta (42%), or associated follow-up clinics of the Western Canadian Complex Pediatric Therapies Project (58%), with no knowledge of the clinical course of these infants except for the intracardiac surgery. The comprehensive assessment has been described.
14,21
In brief, Mental Developmental Index and Performance Developmental Index were determined by the administration of Bayley Scales of Infant Development
22
by certified examiners with experience in testing children with both normal and abnormal outcomes. Neurologic and developmental examinations were completed by a pediatrician experienced in neurodevelopmental follow-up. Behavioral hearing tests were completed in a sound booth by a certified clinical audiologist experienced in testing young children.
The following definitions were used in this study:
that was diagnosed by a constellation of clinical neuromotor abnormalities at 18 to 24 months as agreed by 2 physicians (a neurodevelopmental pediatrician and pediatric neurologist/physiatrist); (2) legal blindness (corrected visual acuity of the better eye <20/200); and/or (3) hearing loss (sensorineural hearing of >40 dB in the better ear). Neurodevelopmental delay was defined as either Mental Developmental Index and/or Performance Developmental Index greater than 2 SD below the mean for normative data (<70) without disability. and are shown in Table 1.
|
Statistical Analysis
Data are expressed as mean ± SD. Differences in the clinical and biochemical measurements between the 3 groups (nonsurvivors, adverse and intact survivors) were compared using 1-way analysis of variance (ANOVA) followed by Scheffé multiple comparison testing. To examine predictability of plasma lactate, concentrations of 4 to 10 mmol/L and 15 mmol/L were used, based on the available literature
15-20
and general consensus of a poor chance of survival, respectively. Their PVs for nonsurvival or adverse outcome were calculated and analyzed with Fisher's exact test. Comparison between 2 proportions was performed with the z test. Statistical software programs, SPSS version 10.07 for Windows (SPSS Inc, Chicago, Ill) and SigmaStat version 2.0 (Jandel Scientific Corp, San Rafael, Calif), were used. Statistical significance was set at P less than .05 except for post hoc Scheffé testing, which was set at P less than .10 as recommended.
|
Results |
|---|
|
TopAbstractIntroductionPatients and MethodsResultsDiscussionConclusionReferences |
|---|
Survivors had shorter cardiopulmonary bypass times and hypothermic arrest times than the nonsurvivors (Table 1). During the early postoperative period, they also had higher arterial pH than the nonsurvivors (7.36 ± 0.08 and 7.33 ± 0.07 of the intact and adverse survivors, respectively, vs 7.26 ± 0.13 of the nonsurvivors, P < .05, ANOVA),
21
but the PAO
2 and base deficit were not different between groups (data not shown).
Plasma Lactate Profile of Infants Treated With Intracardiac Surgery
There were 8 ± 4 (1-22) lactate determinations during the first postoperative day with no differences between groups. Infants of the nonsurvivor group had significantly higher lactate concentrations on admission, at D1 peak, and during hospitalization (highest concentrations) when compared with the adverse and intact survivors, whose lactate concentrations were not different (Table 2). The lactate concentrations on days 2 to 5 and 6 days after intracardiac surgery were also higher in the nonsurvival group.
21
Similar patterns were observed in the subgroup of infants without HLHS; for those with HLHS, nonsurvivors had significantly longer lactime for plasma lactate concentration of 2 mmol/L or less and higher peak lactate during hospitalization than those of intact survivors. The nonsurvivor group also had longer lactimes and greater area under the curve of the lactate profile during day 1 after intracardiac surgery than adverse and intact survivors (P < .001) (Table 2). Adverse survivors had a significantly longer lactime for plasma lactate concentration of 2 mmol/L or less than intact survivors (Table 2). Two nonsurvivors (14%) had lactate concentrations returned to 2 mmol/L or less within 24 hours postoperatively compared with 19 adverse survivors (68%) and 37 intact survivors (86%).
|
|
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionPatients and MethodsResultsDiscussionConclusionReferences |
|---|
Several studies have demonstrated an association between hyperlactatemia and mortality after intracardiac surgery in children.
12,15-20
Our findings support the use of plasma lactate concentrations to predict early survival with an accuracy of more than 80%. Specifically, plasma lactate of less than 7 mmol/L on admission or less than 8 mmol/L at D1 peak predicts survival with a positive PV of 97% in contrast with the prediction of nonsurvival with a positive PV of only 43% for plasma lactate exceeding these levels. In addition, serial plasma lactate determination may help identify those survivors with neurodevelopmental disability or delay as having a longer lactime for the lactate concentration to decrease to 2 mmol/L or less during the first postoperative day than did the intact survivors. Plasma lactate measurement, which is readily available in all hospitals, has the potential to objectively provide predictive information on the outcome of these critically ill neonates during the early postoperative period.
The PV of plasma lactate on mortality has been extensively studied in critically ill adults, but less so in the pediatric population. Several studies confirmed the PV of hyperlactatemia in selected groups of neonates, including those with severe hypoxemia
24
or hypoxemic-ischemic encephalopathy,
13
and after extracorporeal membrane oxygenation.
14
Our results support the use of plasma lactate as an early predictor of outcome in a selected population of critically ill neonates and adds to the literature on predictors of mortality in neonates after intracardiac surgery.
12,15-20
The nonsurvivors had higher plasma lactate on admission and at D1 peak after intracardiac surgery. Although similar patterns were observed in the subgroup of infants without HLHS and to a lesser extent for those with HLHS, our sample size was too small for further analysis of individual cardiac defects. As shown by the lactimes, nonsurvivors also had a slower rate of decline in plasma lactate postoperatively, which was also observed by Munoz and associates
20
in 174 children undergoing operations for congenital heart disease. Munoz and colleagues
20
also noted that hyperlactatemia during cardiopulmonary bypass in 174 patients with intracardiac surgery was associated with postoperative mortality. Charpie and coworkers
15
suggested that serial lactate determination might be an accurate predictor of death within 72 hours postoperatively or requirement for extracorporeal membrane oxygenation support in a prospective study of 46 infants who underwent complex neonatal cardiac surgery.
Siegel and colleagues
12
reported high PVs of lactate concentration in 41 children with intracardiac surgery and indicated that using an admission lactate concentration of greater than 4.2 mmol/L predicted postoperative deaths with a positive PV of 100%. In a study with results similar to ours, Hatherill and associates
19
reported that an initial lactate concentration of greater than 6 mmol/L had poor positive PV (32%) for mortality in a prospective observational study of 99 young children aged 0.38 to 31 months. However, by using admission lactate of 7 mmol/L or greater, we reported higher sensitivity (vs 78%), lower specificity (vs 83%), and similar negative PV (vs 97%). Nonetheless, the overall accuracy of prediction is similar between studies at greater than 80%. The "poor" positive PV may undermine the usefulness of plasma lactate concentration to identify nonsurvivors because of other confounding issues and advances in surgical and perioperative care, which may explain the different and apparent contrasting observations between studies and surgical populations. Indeed, the positive PV value remains less than 100% despite lactate concentrations 15 mmol/L or greater, which may indicate a dismal chance of survival (Table 3). With recognition of this weakness, plasma lactate concentration may predict which infants survive the immediate postoperative course after intracardiac surgery. Lactate concentrations of 7 mmol/L or less on admission or 8 mmol/L or less at D1 peak predicts survival accurately, with a sensitivity of 82% and a positive PV of 97% as shown in our study. Furthermore, although there is a wide range of plasma lactate concentrations used in the prediction (4-7 mmol/L),
12,15-20
the lactate concentration used in our study is consistent with others reporting a mortality of 10% or more.
18,19
Indeed, Munoz and coworkers
20
observed an association between the complexity of intracardiac surgery and the lactate concentration. Therefore, a heterogeneous population of infants with intracardiac surgery may explain the variation in the lactate concentrations used in prediction that may need modification according to institutional experience.
Predicting the neurodevelopmental outcome in critically ill neonates is difficult. From our previous report, almost 40% of the total variance of the long-term outcome remained unaccounted for by known risk factors identified during the preoperative, intraoperative, and postoperative periods.
21
Nonetheless, various risk factors including the deep hypothermic circulatory arrest time,
6
neuroimaging,
7
and electrophysiologic
8
findings, and certain clinical features
9
have been shown to be associated with subsequent neurodevelopmental outcome after intracardiac surgery. The current study is the first we are aware of to examine the PV of plasma lactate on neurodevelopmental outcome in early childhood after intracardiac surgery. This provides an objective assessment that is available early in the course after intracardiac surgery. However, consistent with our previous observation in those neonates requiring extracorporeal membrane oxygenation,
14
the PVs for adverse outcome are lower than those for early mortality. Although mortality is usually related to the extent of organ failure or irreversible dysfunction of multiple organs, which may be reflected in the plasma lactate concentration, the plasma lactate concentration may not indicate the severity of organ-specific hypoxia. Therefore, plasma lactate determination has a lower predictability of the degree of cerebral hypoxemic-ischemic insult in patients with nonlethal systemic hypoxemia. We suggest that serial lactate determination including a detailed examination of the lactate profile may help predict adverse outcome soon after admission to the intensive care unit with an accuracy of 70%. Indeed, the use of lactate concentrations on postoperative days 2 to 5 after cardiac surgery significantly improved the prediction of neurodevelopmental outcome of these patients.
21
In this study, we used the definitions of lactime and area under the curve for the lactate profile in similar fashion to the report by Bakker and coworkers.
24
Bakker's group used the lactime for plasma lactate concentration to decrease to 2 mmol/L or less. They also calculated the theoretical area under the curve assuming a linear regression of the lactate concentration in contrast with our direct measurement using the lactate profile charted individually. In this study, we provided a detailed examination of the role of lactime and a more accurate estimation of the area under the curve of the lactate profile to examine the PV of serial lactate determination. Furthermore, it is important to study the PV of lactate concentrations in neonates rather than in a heterogeneous population of different developmental ages. Lactate metabolism is influenced by developmental changes including maturation of liver enzymes involved in the glucose hexaphosphate shunt. This may explain the high lactate concentrations during the immediate perinatal period that decrease with increasing age.
25
Indeed, because of these developmental changes, a careful interpretation of the lactate concentration profile rather than individual values is warranted, as suggested by Saugstad.
26
|
Conclusion |
|---|
|
TopAbstractIntroductionPatients and MethodsResultsDiscussionConclusionReferences |
|---|
|
Acknowledgments |
|---|
|
Footnotes |
|---|
* The Western Canadian Complex Pediatric Therapies Project, Follow-up Group includes Drs O. Casiro, Children's Hospital, Winnipeg, Manitoba; J. D. Dyck, Stollery Children's Hospital, Edmonton, Alberta; J. R. Harder and R. S. Sauve, Alberta Children's Hospital, Calgary, Alberta; W. Reid, Child Development Centre, Regina, Saskatchewan; and P. Blakley, Kinsmen Children's Centre, Saskatoon, Saskatchewan. 
|
References |
|---|
|
TopAbstractIntroductionPatients and MethodsResultsDiscussionConclusionReferences |
|---|
This article has been cited by other articles:
|
|
 |
|
  A. S. Mackie, G. Y. Alton, I. A. Dinu, A. R. Joffe, S. J. Roth, J. W. Newburger, and C. M. T. Robertson Clinical outcome score predicts the need for neurodevelopmental intervention after infant heart surgery J. Thorac. Cardiovasc. Surg., May 1, 2013; 145(5): 1248 - 1254.e2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nishibe and M. Tsujita The impact of intraoperative vasopressin infusion in complex neonatal cardiac surgery Interact CardioVasc Thorac Surg, December 1, 2012; 15(6): 966 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chasovskyi, O. Fedevych, G. Vorobiova, V. Zhovnir, A. Maksimenko, O. Boychenko, Y. Lysak, G. Cohen, and I. Yemets Arterial Switch Operation in the First Hours of Life Using Autologous Umbilical Cord Blood Ann. Thorac. Surg., May 1, 2012; 93(5): 1571 - 1576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Snookes, J. K. Gunn, B. J. Eldridge, S. M. Donath, R. W. Hunt, M. P. Galea, and L. Shekerdemian A Systematic Review of Motor and Cognitive Outcomes After Early Surgery for Congenital Heart Disease Pediatrics, April 1, 2010; 125(4): e818 - e827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Abraham, P. Prodhan, R. D.B. Jaquiss, A. T. Bhutta, J. M. Gossett, M. Imamura, C. E. Johnson, M. L. Schmitz, W. R. Morrow, and U. Dyamenahalli Cardiopulmonary bypass flow rate: A risk factor for hyperlactatemia after surgical repair of secundum atrial septal defect in children J. Thorac. Cardiovasc. Surg., January 1, 2010; 139(1): 170 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sarajuuri, T. Lonnqvist, L. Mildh, I. Rajantie, M. Eronen, I. Mattila, and E. Jokinen Prospective follow-up study of children with univentricular heart: Neurodevelopmental outcome at age 12 months J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 139 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Sherlock, P. S. McQuillen, S. P. Miller, and on behalf of aCCENT Preventing Brain Injury in Newborns With Congenital Heart Disease: Brain Imaging and Innovative Trial Designs Stroke, January 1, 2009; 40(1): 327 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. D. Durandy, M. Younes, and B. Mahut Pediatric Warm Open Heart Surgery and Prolonged Cross-Clamp Time Ann. Thorac. Surg., December 1, 2008; 86(6): 1941 - 1947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Neufeld, B. G. Clark, C. M.T. Robertson, D. M. Moddemann, I. A. Dinu, A. R. Joffe, R. S. Sauve, D. E. Creighton, L. Zwaigenbaum, D. B. Ross, et al. Five-year neurocognitive and health outcomes after the neonatal arterial switch operation J. Thorac. Cardiovasc. Surg., December 1, 2008; 136(6): 1413 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lequier, A. R. Joffe, C. M.T. Robertson, I. A. Dinu, Y. Wongswadiwat, N. R. Anton, D. B. Ross, I. M. Rebeyka, and Western Canadian Complex Pediatric Therapies Progr Two-year survival, mental, and motor outcomes after cardiac extracorporeal life support at less than five years of age. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 976 - 983.e3. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Atallah, I. A. Dinu, A. R. Joffe, C. M.T. Robertson, R. S. Sauve, J. D. Dyck, D. B. Ross, I. M. Rebeyka, and the Western Canadian Complex Pediatric Therapies F Two-Year Survival and Mental and Psychomotor Outcomes After the Norwood Procedure: An Analysis of the Modified Blalock-Taussig Shunt and Right Ventricle-to-Pulmonary Artery Shunt Surgical Eras Circulation, September 30, 2008; 118(14): 1410 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wernovsky Improving neurologic and quality-of-life outcomes in children with congenital heart disease: Past, present, and future J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 240 - 242. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Gasparovic, S. Plestina, Z. Sutlic, I. Husedzinovic, V. Coric, V. Ivancan, and I. Jelic Pulmonary lactate release following cardiopulmonary bypass Eur J Cardiothorac Surg, December 1, 2007; 32(6): 882 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Miyaji, S. Kohira, T. Miyamoto, K. Nakashima, H. Sato, K. Ohara, and H. Yoshimura Pediatric cardiac surgery without homologous blood transfusion, using a miniaturized bypass system in infants with lower body weight J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 284 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Freed, C. M.T. Robertson, R. S. Sauve, A. R. Joffe, I. M. Rebeyka, D. B. Ross, J. D. Dyck, and the Western Canadian Complex Pediatric Therapies P Intermediate-term outcomes of the arterial switch operation for transposition of great arteries in neonates: Alive but well? J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 845 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Padula and A. M. Ades Neurodevelopmental Implications of Congenital Heart Disease NeoReviews, July 1, 2006; 7(7): e363 - e369. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
